US FDA

US FDA Approves MRM Health’s MH002 Phase 2b Study In Mild-To-Moderate Ulcerative Colitis

US FDA Approves MRM Health’s MH002 Phase 2b Study In Mild-To-Moderate Ulcerative Colitis

10 Jan 2026

1 min read

US FDA Accepts Priority Review For Sanofi’s Tzield sBLA In Children With Stage 2 Type 1 Diabetes

US FDA Accepts Priority Review For Sanofi’s Tzield sBLA In Children With Stage 2 Type 1 Diabetes

06 Jan 2026

1 min read

US FDA Approves Omeros Drug For Treatment Of Serious Transplant Complication

US FDA Approves Omeros Drug For Treatment Of Serious Transplant Complication

29 Dec 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com